Exforge HCT is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Amlodipine Besylate; Valsartan; Hydrochlorothiazide.
Product ID | 0078-0563_10b0a131-e828-48e1-9e2b-92a6bbcb753a |
NDC | 0078-0563 |
Product Type | Human Prescription Drug |
Proprietary Name | Exforge HCT |
Generic Name | Amlodipine Valsartan And Hydrochlorothiazide |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2009-04-04 |
Marketing Category | NDA / NDA |
Application Number | NDA022314 |
Labeler Name | Novartis Pharmaceuticals Corporation |
Substance Name | AMLODIPINE BESYLATE; VALSARTAN; HYDROCHLOROTHIAZIDE |
Active Ingredient Strength | 10 mg/1; mg/1; mg/1 |
Pharm Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2009-04-04 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022314 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-04-04 |
Marketing End Date | 2014-06-19 |
Marketing Category | NDA |
Application Number | NDA022314 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-04-04 |
Marketing End Date | 2019-04-30 |
Marketing Category | NDA |
Application Number | NDA022314 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-04-04 |
Ingredient | Strength |
---|---|
AMLODIPINE BESYLATE | 10 mg/1 |
SPL SET ID: | 18d7820d-471f-4ee2-9ec6-25d8d27c77de |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0078-0559 | Exforge HCT | amlodipine valsartan and hydrochlorothiazide |
0078-0560 | Exforge HCT | amlodipine valsartan and hydrochlorothiazide |
0078-0561 | Exforge HCT | amlodipine valsartan and hydrochlorothiazide |
0078-0562 | Exforge HCT | amlodipine valsartan and hydrochlorothiazide |
0078-0563 | Exforge HCT | amlodipine valsartan and hydrochlorothiazide |
0781-5756 | AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | amlodipine valsartan and hydrochlorothiazide |
0781-5760 | AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | amlodipine valsartan and hydrochlorothiazide |
0781-5771 | AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | amlodipine valsartan and hydrochlorothiazide |
0781-5787 | AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | amlodipine valsartan and hydrochlorothiazide |
0781-5794 | AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | amlodipine valsartan and hydrochlorothiazide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
EXFORGE HCT 77202989 3923438 Live/Registered |
Novartis AG 2007-06-11 |